Health Catalyst Q2 revenue $80.7M (+6% YoY), EBITDA $9.3M beat; CEO to retire June 2026

Health Catalyst, Inc.

2025-Q2 EPS reported -$0.94 vs consensus $0.03 ▼ miss (-2816.8%)

Total revenue $80.7M (+6% YoY); Adjusted EBITDA $9.3M; both beat Q2 guidance.
Net loss widened 203% to $41.0M from $13.5M in prior year.
CEO Dan Burton to retire effective June 30, 2026; will remain on Board; CEO search initiated.
Board expanded to 8 directors; Justin Spencer (CFO Eko Health) appointed effective Sep 1, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.